It’s changing of the guard time at pharmaceutical giant Bristol Myers Squibb. On Wednesday, CEO Giovanni Caforio will step down. He’ll be replaced by Christopher Boerner, who is currently chief ...

Bristol Myers Squibb (BMS) is restructuring its leadership team as its CEO Giovanni Caforio announced he will be retiring later this year after 23 years at the company. BMS announced Wednesday that ...

In a surprise announcement Wednesday, Bristol Myers Squibb said its CEO Giovanni Caforio, M.D., will end his eight-year tenure and hand the baton to Chief Commercialization Officer Chris Boerner.

Bristol Myers Squibb said on Wednesday CEO Giovanni Caforio will step down in November and be succeeded by Chief Commercialization Officer Christopher Boerner. Boerner, who has been CCO since 2018, ...

"I look forward to his continued contributions to patients, shareholders and employees as a member of the Board of Directors." NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today ...

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced a number of leadership changes approved by its board of directors and effective at the close of the annual ...

Bristol-Myers Squibb Company (BMY) Q2 2020 Earnings Conference Call August 6, 2020 8:30 AM ET Company Participants Tim Power - VP IR Giovanni Caforio - Chairman and CEO David Elkins - CFO Chris ...

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that the company’s Board of Directors has appointed Giovanni Caforio, M.D. as chairman of the board, effective May 2, ...

CNBC'S JIM CRAMER INTERVIEWS BRISTOL MYERS SQUIBB CHAIRMAN AND CEO GIOVANNI CAFORIO FROM CNBC'S HEALTHY RETURNS SUMMIT TODAY WHEN: Today, Tuesday, May 12, 2020 Following is the unofficial transcript ...

NEW YORK—Bristol-Myers Squibb has appointed Giovanni Caforio, M.D., as COO. The pharmaceutical company announced Monday that Carforio, who has been with Bristol-Myers Squibb since 2000, had been ...

Great. Okay. Good morning. I'm Tim Anderson. I'm the large-cap pharma and biotech analyst of Wolfe Research. And for the next 45 minutes, we'll be talking with Bristol-Myers Squibb's Giovanni Caforio.

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that Giovanni Caforio, M.D., has been appointed chief operating officer and elected to Bristol-Myers Squibb's Board ...